[HTML][HTML] Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

H Magnussen, S Lucas, T Lapperre, JK Quint… - Respiratory …, 2021 - Springer
Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

H Magnussen, S Lucas, T Lapperre… - Respiratory …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

[PDF][PDF] Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: Observational comparative effectiveness study

H Magnussen, SJ Lucas, TS Lapperre… - Respiratory …, 2021 - aura.abdn.ac.uk
Background: Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study.

H Magnussen, S Lucas, T Lapperre, JK Quint… - Respiratory …, 2021 - europepmc.org
Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

H Magnussen, S Lucas, T Lapperre… - Respiratory …, 2021 - repository.uantwerpen.be
BackgroundInhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

H Magnussen, S Lucas, T Lapperre… - Respiratory …, 2021 - search.proquest.com
Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

H Magnussen, S Lucas, T Lapperre, JK Quint… - RESPIRATORY …, 2021 - sfera.unife.it
Background: Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

[PDF][PDF] Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

H Magnussen, S Lucas, T Lapperre, JK Quint… - 2021 - scholar.archive.org
Background: Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

[PDF][PDF] Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

H Magnussen, S Lucas, T Lapperre, JK Quint… - 2021 - core.ac.uk
Background: Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

[HTML][HTML] Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study

H Magnussen, S Lucas… - Respiratory …, 2021 - respiratory-research.biomedcentral …
Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in patients with
COPD, but they are frequently overprescribed. ICS withdrawal has been recommended by …